CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 126 filers reported holding CASTLE BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,120,000 | +11.2% | 203,300 | +6.3% | 0.08% | +21.2% |
| Q4 2021 | $8,198,000 | +140.6% | 191,225 | +273.2% | 0.07% | +144.4% |
| Q3 2021 | $3,407,000 | -8.6% | 51,233 | +0.8% | 0.03% | -3.6% |
| Q2 2021 | $3,728,000 | -10.3% | 50,844 | -16.2% | 0.03% | -9.7% |
| Q1 2021 | $4,154,000 | -6.0% | 60,678 | -7.8% | 0.03% | -8.8% |
| Q4 2020 | $4,417,000 | -2.7% | 65,784 | -25.4% | 0.03% | -20.9% |
| Q3 2020 | $4,539,000 | +28.1% | 88,219 | -6.1% | 0.04% | +16.2% |
| Q2 2020 | $3,542,000 | +34.2% | 93,975 | +6.2% | 0.04% | +5.7% |
| Q1 2020 | $2,639,000 | -2.4% | 88,523 | +12.5% | 0.04% | +45.8% |
| Q4 2019 | $2,703,000 | +113.5% | 78,655 | +12.4% | 0.02% | +84.6% |
| Q3 2019 | $1,266,000 | – | 70,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |